Draft Guidance on HLA Test Kits Raises Concerns of Delays, Costs

The FDA’s draft guidance on 510(k) submissions for nucleic acid-based HLA test kits has raised concerns about manufacturing delays for new test kits and increased costs for devicemakers.
Devices & Diagnostics Letter